Boramae Neurology

Medicine & Life Sciences

1. Stroke 100%
2. Parkinson Disease 91%
3. Amyotrophic Lateral Sclerosis 46%
4. Deep Brain Stimulation 34%
5. Myasthenia Gravis 31%
6. Brain Infarction 29%
7. Cerebral Small Vessel Diseases 29%
8. Epilepsy 26%
9. White Matter 26%
10. REM Sleep Behavior Disorder 25%
11. Korea 24%
12. Sleep 21%
13. Odds Ratio 20%
14. Multiple System Atrophy 20%
15. Confidence Intervals 19%
16. Brain 19%
17. Levodopa 19%
18. Magnetic Resonance Imaging 18%
19. Intracranial Arteriosclerosis 18%
20. Pathologic Constriction 18%
21. Subthalamic Nucleus 17%
22. Seizures 16%
23. Infarction 15%
24. Mental Status and Dementia Tests 14%
25. Dyskinesias 14%
26. Parkinsonian Disorders 13%
27. Obstructive Sleep Apnea 13%
28. Population 13%
29. Single-Photon Emission-Computed Tomography 12%
30. Cognition 12%
31. Cilostazol 12%
32. Cognitive Dysfunction 11%
33. Temporal Lobe Epilepsy 11%
34. Lacunar Stroke 11%
35. Metabolic Syndrome 10%
36. Middle Cerebral Artery 10%
37. Glycogen Synthase Kinase 3 10%
38. Blood Pressure 10%
39. Levetiracetam 10%
40. eculizumab 10%
41. Doppler Transcranial Ultrasonography 10%
42. Therapeutics 10%
43. Electroencephalography 10%
44. Brain Ischemia 10%
45. Mutation 10%
46. Biomarkers 9%
47. Arteries 9%
48. Antibodies 9%
49. Neuroimaging 9%
50. Neuroprotective Agents 9%
51. Placebos 9%
52. Cerebral Hemorrhage 9%
53. Dementia 9%
54. 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane 9%
55. Electrodes 9%
56. Muscles 9%
57. Aspirin 8%
58. Magnetic Resonance Angiography 8%
59. Randomized Controlled Trials 8%
60. Motor Neurons 8%
61. Disruptive, Impulse Control, and Conduct Disorders 8%
62. Tremor 8%
63. Hallucinations 8%
64. Brain Stem 8%
65. Polysomnography 8%
66. Positron-Emission Tomography 8%
67. Safety 8%
68. Snoring 8%
69. Diffusion Tensor Imaging 8%
70. Gray Matter 8%
71. Ischemia 7%
72. Cholinergic Receptors 7%
73. Incidence 7%
74. Partial Epilepsy 7%
75. Dopamine Plasma Membrane Transport Proteins 7%
76. Anisotropy 7%
77. Memory 7%
78. Atrophy 7%
79. Neutrophils 7%
80. Behavior Control 7%
81. Polyneuropathies 7%
82. Drug Resistant Epilepsy 7%
83. Transient Ischemic Attack 7%
84. Republic of Korea 7%
85. Elderly 7%
86. Cross-Sectional Studies 6%
87. Pharmaceutical Preparations 6%
88. Glucose 6%
89. Sleep Initiation and Maintenance Disorders 6%
90. Neuromyelitis Optica 6%
91. Putamen 6%
92. Atherosclerosis 6%
93. Perfusion 6%
94. Hypertension 6%
95. Muscular Atrophy 6%
96. Cohort Studies 6%
97. Lymphocytes 6%
98. Disease Progression 6%
99. DA-9701 6%
100. Neuropsychological Tests 6%